• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

幽门螺杆菌空泡毒素相关蛋白A重组蛋白的构建、克隆及表达 （你提供的原文不完整，推测补充了“Helicobacter pylori vacuolating cytotoxin-associated protein A”后的完整内容，以便你参考准确译文）

Construction, Cloning, and Expression of CagA Recombinant Protein of .

作者信息

Shapouri Moghaddam Abbas, Mansouri Shamseddin, Neshani Alireza, Firoozeh Farzaneh, Matinpur Azade, Khaledi Azad, Ghazalibina Mehran

机构信息

Department of Immunology, BuAli Research Institute, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Antimicrobial Resistance Research Center, Department of Microbiology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Avicenna J Med Biotechnol. 2020 Apr-Jun;12(2):135-138.

PMID:32431799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7229452/
Abstract

BACKGROUND

This study aimed to assess construction and expression of CagA recombinant protein of in BL21.

METHODS

Bioinformatics was used in designing the desired gene by Gene Runner. Next, the construct was subcloned to pET21b vector and this process was confirmed by Polymerase Chain Reaction (PCR), enzyme digestion and sequencing techniques. Then, it was cloned in the Escherichia coli BL21 as an expression host. Expression of protein was verified using sodium dodecyl sulfate- polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting technique. For purification of the protein, the Ni-NTA column was used. Protein concentration was determined by the Bicinchoninic Acid Protein Assay Kit (Parstoos). Finally, Western blotting was performed using CagA antibodies and normal human serum for determining immunogenicity feature with human antiserum.

RESULTS

According to the results of the present study, CagA construct was cloned into the pET21b vector and after confirmation and cloning in host expression, recombinant protein with the size of 38 was successfully expressed and purified. The recombinant CagA protein showed immunogenicity characteristics with human antiserum.

CONCLUSION

In conclusion, only 5'-end of recombinant protein CagA with high immunogenicity effects was successfully constructed, cloned and expressed. Also, CagA recombinant protein showed good immunogenicity activity with human antiserum.

摘要

背景

本研究旨在评估空肠弯曲菌CagA重组蛋白在大肠杆菌BL21中的构建与表达。

方法

运用生物信息学通过Gene Runner软件设计所需基因。接着，将构建体亚克隆至pET21b载体，此过程通过聚合酶链反应（PCR）、酶切及测序技术得以证实。随后，将其克隆至大肠杆菌BL21作为表达宿主。使用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳（SDS-PAGE）和蛋白质免疫印迹技术验证蛋白表达。为纯化该蛋白，使用镍-亚氨基二乙酸（Ni-NTA）柱。通过二辛可宁酸蛋白测定试剂盒（帕斯托斯）测定蛋白浓度。最后，使用CagA抗体和正常人血清进行蛋白质免疫印迹，以确定该蛋白与人抗血清的免疫原性特征。

结果

根据本研究结果，CagA构建体被克隆至pET21b载体，经确认并在宿主中表达克隆后，成功表达并纯化出大小为38 kDa的重组蛋白。重组CagA蛋白与人抗血清表现出免疫原性特征。

结论

总之，仅具有高免疫原性效应的重组蛋白CagA的5'端成功构建、克隆并表达。此外，CagA重组蛋白与人抗血清表现出良好的免疫原性活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/1c3fa9ef9451/AJMB-12-135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/3729da05ddff/AJMB-12-135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/2b80ab224db8/AJMB-12-135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/1c3fa9ef9451/AJMB-12-135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/3729da05ddff/AJMB-12-135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/2b80ab224db8/AJMB-12-135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90e5/7229452/1c3fa9ef9451/AJMB-12-135-g003.jpg

相似文献

1
Construction, Cloning, and Expression of CagA Recombinant Protein of .幽门螺杆菌空泡毒素相关蛋白A重组蛋白的构建、克隆及表达 （你提供的原文不完整，推测补充了“Helicobacter pylori vacuolating cytotoxin-associated protein A”后的完整内容，以便你参考准确译文）
Avicenna J Med Biotechnol. 2020 Apr-Jun;12(2):135-138.
2
[Production of a recombinant CagA protein for the detection of Helicobacter pylori CagA antibodies].用于检测幽门螺杆菌CagA抗体的重组CagA蛋白的制备
Mikrobiyol Bul. 2014 Jul;48(3):402-12. doi: 10.5578/mb.7642.
3
Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.表达幽门螺杆菌HspA和18,000 M(r)外膜蛋白的二价候选疫苗的构建与特性分析
World J Gastroenterol. 2003 Aug;9(8):1756-61. doi: 10.3748/wjg.v9.i8.1756.
4
[Construction, expression and antigenic study of bivalent vaccine candidate with 26,000 OMP and heat short protein A of human Helicobacter pylori].[人幽门螺杆菌26000外膜蛋白与热休克蛋白A二价候选疫苗的构建、表达及抗原性研究]
Zhonghua Yi Xue Za Zhi. 2003 May 25;83(10):862-7.
5
Construction of prokaryotic expression system of 2 148-bp fragment from cagA gene and detection of cagA gene, CagA protein in Helicobacter pylori isolates and its antibody in sera of patients.构建幽门螺杆菌cagA基因2148bp片段的原核表达系统，并检测幽门螺杆菌分离株中的cagA基因、CagA蛋白及其患者血清中的抗体。
World J Gastroenterol. 2004 Apr 15;10(8):1183-90. doi: 10.3748/wjg.v10.i8.1183.
6
Cloning, expression and purification flagellar sheath adhesion of Helicobacter pylori in Escherichia coli host as a vaccination target.幽门螺杆菌鞭毛鞘黏附蛋白在大肠杆菌宿主中的克隆、表达及纯化作为疫苗靶点
Clin Exp Vaccine Res. 2016 Jan;5(1):19-25. doi: 10.7774/cevr.2016.5.1.19. Epub 2016 Jan 27.
7
Cloning and expression of a recombinant CagA -gene fragment of Helicobacter pylori and its preliminary evaluation in serodiagnosis.幽门螺杆菌重组CagA基因片段的克隆、表达及其在血清学诊断中的初步评价
Biomedica. 2013 Oct-Dec;33(4):546-53. doi: 10.7705/biomedica.v33i4.1678.
8
[Construction, expression and antigenicity of bivalent vaccine candidate of human Helicobacter pylori].[人幽门螺杆菌双价候选疫苗的构建、表达及抗原性]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 Jan;20(1):62-6.
9
Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA.携带幽门螺杆菌hpaA的重组减毒鼠伤寒沙门氏菌DNA疫苗的构建
World J Gastroenterol. 2005 Jan 7;11(1):114-7. doi: 10.3748/wjg.v11.i1.114.
10
[Detection of cagA gene, CagA protein in Helicobacter pylori isolates and its antibody in serum of patients with gastric diseases by a recombinant protein CagA 1].[用重组蛋白CagA 1检测幽门螺杆菌分离株中的cagA基因、CagA蛋白及其在胃病患者血清中的抗体]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 May;34(3):223-9. doi: 10.3785/j.issn.1008-9292.2005.03.007.

引用本文的文献

1
Developing a potent vaccine against : critical considerations and challenges.开发针对……的有效疫苗：关键考量与挑战
Expert Rev Mol Med. 2024 Nov 25;27:e12. doi: 10.1017/erm.2024.19.
2
How Long Will It Take to Launch an Effective Vaccine for Humans?研发出一款对人类有效的疫苗需要多长时间？
Infect Drug Resist. 2023 Jun 15;16:3787-3805. doi: 10.2147/IDR.S412361. eCollection 2023.
3
Transient recombinant expression of highly immunogenic and in .高免疫原性的瞬时重组表达以及在……中

本文引用的文献

1
Epinecidin-1, a highly potent marine antimicrobial peptide with anticancer and immunomodulatory activities.海鞘抗菌肽 1，一种具有抗肿瘤和免疫调节活性的高效海洋抗菌肽。
BMC Pharmacol Toxicol. 2019 May 28;20(1):33. doi: 10.1186/s40360-019-0309-7.
2
Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.布鲁氏菌和幽门螺杆菌总外膜蛋白- CagA 组合对 BALB/c 小鼠模型血清杀菌和脾脏活性的研究。
Microb Pathog. 2018 Aug;121:100-105. doi: 10.1016/j.micpath.2018.04.050. Epub 2018 Apr 27.
3
Echoes of a distant past: The cag pathogenicity island of Helicobacter pylori.
Biotechnol Rep (Amst). 2021 Dec 29;33:e00699. doi: 10.1016/j.btre.2021.e00699. eCollection 2022 Mar.
遥远过去的回响：幽门螺杆菌的 cag 致病岛。
Cold Spring Harb Perspect Med. 2013 Nov 1;3(11):a010355. doi: 10.1101/cshperspect.a010355.
4
Production of recombinant streptokinase in E. coli and reactivity with immunized mice.重组链激酶在大肠杆菌中的生产及其与免疫小鼠的反应性。
Pak J Biol Sci. 2010 Apr 15;13(8):380-4. doi: 10.3923/pjbs.2010.380.384.
5
Molecular cloning, expression, purification and immunological characterization of three low-molecular weight proteins encoded by genes in genomic regions of difference of mycobacterium tuberculosis.结核分枝杆菌基因差异区编码的三个低分子量蛋白的分子克隆、表达、纯化和免疫特性分析。
Scand J Immunol. 2010 May;71(5):353-61. doi: 10.1111/j.1365-3083.2010.02388.x.
6
Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.在被动免疫的乳鼠模型中，抗体介导的对幽门螺杆菌感染的保护作用。
Infect Immun. 2009 Nov;77(11):5116-29. doi: 10.1128/IAI.00547-09. Epub 2009 Sep 8.
7
Diversity of Helicobacter pylori isolates in expression of antigens and induction of antibodies.幽门螺杆菌分离株在抗原表达及抗体诱导方面的多样性。
World J Gastroenterol. 2008 Aug 14;14(30):4816-22. doi: 10.3748/wjg.14.4816.
8
Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.Th1偏向型免疫反应与Th2偏向型免疫反应在小鼠抵抗幽门螺杆菌攻击中的保护作用
Microb Pathog. 2008 Jan;44(1):20-7. doi: 10.1016/j.micpath.2007.06.006. Epub 2007 Jul 5.
9
Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics.幽门螺杆菌阳性和阴性十二指肠溃疡患者具有不同的临床特征。
World J Gastroenterol. 2005 Jun 21;11(23):3518-22. doi: 10.3748/wjg.v11.i23.3518.
10
Expression of the CagA gene ofH. pylori and application of its product.幽门螺杆菌CagA基因的表达及其产物的应用。
World J Gastroenterol. 2000 Feb;6(1):122-124. doi: 10.3748/wjg.v6.i1.122.